Amgen holders put $8.9 million LYONs, $2.24 billion zero-coupon convertibles

By Angela McDaniels

Seattle, March 2 - Amgen Inc. said holders put back $8.9 million principal amount at maturity of the company's Liquid Yield Option Notes (LYONs) due 2032 and $2.24 billion principal amount at maturity of its zero-coupon convertible notes due 2032 during a put option that ended on Thursday.

The purchase price for both series of notes was $755.44 per $1,000 principal amount at maturity.

The company paid $6.7 million to redeem the LYONs and $1.7 billion to redeem the zero-coupon convertibles.

About $1.8 million principal amount at maturity of the LYONs and $103.3 million principal amount at maturity of the zero-coupon convertibles remains outstanding, according to an 8-K report filed with the Securities and Exchange Commission on Friday.

Amgen is a biotechnology company based in Thousand Oaks, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.